• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟失重条件下莫西沙星在动物模型中的口服吸收和药物相互作用动力学。

Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX, 77004, USA.

Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA.

出版信息

Sci Rep. 2021 Jan 28;11(1):2605. doi: 10.1038/s41598-021-82044-3.

DOI:10.1038/s41598-021-82044-3
PMID:33510326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7843972/
Abstract

To investigate the effect of simulated weightlessness on the pharmacokinetics of orally administered moxifloxacin and the antacid Maalox or the antidiarrheal Pepto-Bismol using a tail-suspended (TS) rat model of microgravity. Fasted control and TS, jugular-vein-cannulated, male Sprague-Dawley rats received either a single 5 mg/kg intravenous dose or a single 10 mg/kg oral dose of moxifloxacin alone or with a 0.625 mL/kg oral dose of Maalox or a 1.43 mL/kg oral dose of Pepto-Bismol. Plasma concentrations of moxifloxacin were measured by HPLC. Pharmacokinetic data were analyzed using WinNonlin. Simulated weightlessness had no effect on moxifloxacin disposition after intravenous administration but significantly decreased the extent of moxifloxacin oral absorption. The coadministration of moxifloxacin with Maalox to either control or TS rats caused significant reductions in the rate and extent of moxifloxacin absorption. In contrast, the coadministration of moxifloxacin with Pepto-Bismol to TS rats had no significant effect on either the rate or the extent of moxifloxacin absorption. These interactions showed dose staggering when oral administrations of Pepto-Bismol and moxifloxacin were separated by 60 min in control rats but not in TS rats. Dose staggering was more apparent after the coadministration of Maalox and moxifloxacin in TS rats.

摘要

为了研究模拟失重对口服莫西沙星的药代动力学的影响,采用尾吊(TS)大鼠模型进行了研究。禁食对照和 TS 、颈静脉插管雄性 Sprague-Dawley 大鼠分别给予单剂量 5mg/kg 静脉注射或单剂量 10mg/kg 口服莫西沙星,或同时给予 0.625ml/kg 口服 Maalox 或 1.43ml/kg 口服 Pepto-Bismol。采用 HPLC 法测定莫西沙星的血浆浓度。采用 WinNonlin 分析药代动力学数据。模拟失重对静脉给药后莫西沙星的处置没有影响,但显著降低了莫西沙星口服吸收的程度。莫西沙星与 Maalox 同时给予对照或 TS 大鼠,均显著降低了莫西沙星的吸收速率和程度。相反,莫西沙星与 Pepto-Bismol 同时给予 TS 大鼠,对莫西沙星的吸收速率或程度均无显著影响。这些相互作用在对照大鼠中,当口服 Pepto-Bismol 和莫西沙星之间间隔 60 分钟时,表现出剂量错开现象,但在 TS 大鼠中则没有。在 TS 大鼠中,莫西沙星与 Maalox 同时给药时,剂量错开现象更为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/7843972/e286d6d5d366/41598_2021_82044_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/7843972/4a684f1f4d83/41598_2021_82044_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/7843972/f090a23a6476/41598_2021_82044_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/7843972/e286d6d5d366/41598_2021_82044_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/7843972/4a684f1f4d83/41598_2021_82044_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/7843972/f090a23a6476/41598_2021_82044_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c24e/7843972/e286d6d5d366/41598_2021_82044_Fig3_HTML.jpg

相似文献

1
Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness.模拟失重条件下莫西沙星在动物模型中的口服吸收和药物相互作用动力学。
Sci Rep. 2021 Jan 28;11(1):2605. doi: 10.1038/s41598-021-82044-3.
2
Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids.口服抗流感神经氨酸酶抑制剂前药奥司他韦与抗酸剂之间不存在药代动力学相互作用。
Br J Clin Pharmacol. 2002 Oct;54(4):372-7. doi: 10.1046/j.1365-2125.2002.01678.x.
3
Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.对健康志愿者口服400毫克剂量莫西沙星后,抗酸剂和H2拮抗剂对其吸收影响的评估。
Clin Pharmacokinet. 2001;40 Suppl 1:39-48. doi: 10.2165/00003088-200140001-00006.
4
Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate.口服含八硫酸蔗糖铋、碱式水杨酸铋和枸橼酸铋钾制剂后,Sprague-Dawley大鼠对铋的吸收比较
Biopharm Drug Dispos. 1997 Jan;18(1):1-8. doi: 10.1002/(sici)1099-081x(199701)18:1<1::aid-bdd996>3.0.co;2-0.
5
Lack of interaction between valaciclovir, the L-valyl ester of acyclovir, and Maalox antacid.伐昔洛韦(阿昔洛韦的L-缬氨酸酯)与氢氧化铝镁抗酸剂之间不存在相互作用。
J Antimicrob Chemother. 1996 Feb;37(2):383-7. doi: 10.1093/jac/37.2.383.
6
Gender differences in pharmacokinetics of antipyrine in a simulated weightlessness rat model.
Aviat Space Environ Med. 2012 Jan;83(1):8-13. doi: 10.3357/asem.3153.2012.
7
Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.抗酸剂氢氧化铝镁混悬液和H2拮抗剂西咪替丁对西立伐他汀药代动力学的影响。
Int J Clin Pharmacol Ther. 1997 Jun;35(6):261-4.
8
Interaction of meloxicam with cimetidine, Maalox, or aspirin.美洛昔康与西咪替丁、氢氧化铝镁混悬液或阿司匹林的相互作用。
J Clin Pharmacol. 1996 Jan;36(1):79-84. doi: 10.1002/j.1552-4604.1996.tb04155.x.
9
Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.利奈唑胺与抗酸剂在健康志愿者中不存在药代动力学相互作用。
Antimicrob Agents Chemother. 2006 Jan;50(1):68-72. doi: 10.1128/AAC.50.1.68-72.2006.
10
Effect of Maalox on the oral absorption of sparfloxacin.氢氧化铝镁混悬液对司帕沙星口服吸收的影响。
Clin Ther. 1998 Nov-Dec;20(6):1149-58. doi: 10.1016/s0149-2918(98)80110-0.

引用本文的文献

1
Alteration of Gastrointestinal Function and the Ameliorative Effects of Polysaccharides in Tail Suspension Rats.尾悬吊大鼠胃肠道功能的改变及多糖的改善作用
Nutrients. 2025 Feb 18;17(4):724. doi: 10.3390/nu17040724.
2
Effect of Dexketoprofen on the Disposition Kinetics of Moxifloxacin in Plasma and Lung in Male and Female Rats.地氟烷对雄性和雌性大鼠血浆和肺中莫西沙星处置动力学的影响。
Curr Drug Metab. 2024;25(1):63-70. doi: 10.2174/0113892002282271231219044508.
3
Mucosal Adhesive Chitosan Nanogel Formulations of Antibiotics and Adjuvants (Terpenoids, Flavonoids, etc.) and Their Potential for the Treatment of Infectious Diseases of the Gastrointestinal Tract.

本文引用的文献

1
Medications in Space: In Search of a Pharmacologist's Guide to the Galaxy.太空药物:探索药剂师的银河指南。
Pharm Res. 2019 Aug 14;36(10):148. doi: 10.1007/s11095-019-2679-3.
2
Intestinal Absorption and Factors Influencing Bioavailability of Magnesium-An Update.肠道对镁的吸收及影响其生物利用度的因素——最新进展
Curr Nutr Food Sci. 2017 Nov;13(4):260-278. doi: 10.2174/1573401313666170427162740.
3
Drugs in space: Pharmacokinetics and pharmacodynamics in astronauts.太空药物:宇航员的药代动力学和药效学。
抗生素与佐剂(萜类、黄酮类等)的黏膜黏附性壳聚糖纳米凝胶制剂及其治疗胃肠道传染病的潜力
Pharmaceutics. 2023 Sep 20;15(9):2353. doi: 10.3390/pharmaceutics15092353.
Eur J Pharm Sci. 2017 Nov 15;109S:S2-S8. doi: 10.1016/j.ejps.2017.05.025. Epub 2017 May 19.
4
Pharmacokinetic Profile of Oral Magnesium Hydroxide.口服氢氧化镁的药代动力学特征
Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):264-269. doi: 10.1111/bcpt.12642. Epub 2017 Jan 11.
5
Medication use by U.S. crewmembers on the International Space Station.美国国际空间站机组人员的药物使用情况。
FASEB J. 2015 Nov;29(11):4417-23. doi: 10.1096/fj.14-264838. Epub 2015 Jul 17.
6
Broad-spectrum antibiotic or G-CSF as potential countermeasures for impaired control of bacterial infection associated with an SPE exposure during spaceflight.广谱抗生素或粒细胞集落刺激因子作为应对太空飞行期间与太空辐射暴露相关的细菌感染控制受损的潜在对策。
PLoS One. 2015 Mar 20;10(3):e0120126. doi: 10.1371/journal.pone.0120126. eCollection 2015.
7
Non-invasive panel tests for gastrointestinal motility monitoring within the MARS-500 Project.用于 MARS-500 项目中胃肠动力监测的非侵入性成套检测。
World J Gastroenterol. 2013;19(14):2208-16. doi: 10.3748/wjg.v19.i14.2208.
8
Infection prevention and control during prolonged human space travel.长期载人航天飞行中的感染预防与控制。
Clin Infect Dis. 2013 Jan;56(1):123-30. doi: 10.1093/cid/cis861. Epub 2012 Oct 9.
9
Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.含莫西沙星和枸橼酸铋钾四联疗法作为幽门螺杆菌的一线治疗。
World J Gastroenterol. 2012 Aug 28;18(32):4386-90. doi: 10.3748/wjg.v18.i32.4386.
10
Mass spectrometic study of speciation in aluminium-fluoroquinolone solutions.
Eur J Mass Spectrom (Chichester). 2012;18(3):313-22. doi: 10.1255/ejms.1183.